The association of genetic variants of matrix metalloproteinases with abdominal aortic aneurysm: A systematic review and meta-analysis

Heart

Volumn 100, Issue 4, 2014, Pages 295-302

  Morris, Dylan R ^a   Biros, Erik ^a   Cronin, Oliver ^a   Kuivaniemi, Helena ^b   Golledge, Jonathan ^a,c  

^a JAMES COOK UNIVERSITY   (Australia)

^b WEIS CENTER FOR RESEARCH   (United States)

^c TOWNSVILLE HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AORTIC ANEURYSM, ABDOMINAL; GENE EXPRESSION REGULATION; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; HUMANS; MATRIX METALLOPROTEINASES; RISK FACTORS;

EID: 84893726110     PISSN: 13556037     EISSN: 1468201X     Source Type: Journal    
DOI: 10.1136/heartjnl-2013-304129     Document Type: Review

References (30)

1. Conway AM, Malkawi AH, Hinchliffe RJ, et al. First-year results of a national abdominal aortic aneurysm screening programme in a single centre. Br J Surg 2012;99:73-7.
2. Go AS, Mozaffarian D, Roger VL, et al. Heart disease and stroke statistics-2013 update: a report from the American Heart Association. Circulation 2013;127: e6-e245.
3. Golledge J, Muller J, Daugherty A, et al. Abdominal aortic aneurysm: pathogenesis and implications for management. Arterioscler Thromb Vasc Biol 2006;26:2605-13.
4. Wahlgren CM, Larsson E, Magnusson PK, et al. Genetic and environmental contributions to abdominal aortic aneurysm development in a twin population. J Vasc Surg 2010;51:3-7.
5. Harrison SC, Holmes MV, Agu O, et al. Genome wide association studies of abdominal aortic aneurysms -biological insights and potential translation applications. Atherosclerosis 2011;217:47-56.
6. Hinterseher I, Tromp G, Kuivaniemi H. Genes and abdominal aortic aneurysm. Ann Vasc Surg 2011;25:388-412.
7. Aziz F, Kuivaniemi H. Role of matrix metalloproteinase inhibitors in preventing abdominal aortic aneurysm. Ann Vasc Surg 2007;21:392-401. (Pubitemid 46678660)
8. Saracini C, Bolli P, Sticchi E, et al. Polymorphisms of genes involved in extracellular matrix remodeling and abdominal aortic aneurysm. J Vasc Surg 2012;55:171-9.
9. Duellman T, Warren CL, Peissig P, et al. Matrix metalloproteinase-9 genotype as a potential genetic marker for abdominal aortic aneurysm. Circ Cardiovasc Genet 2012;5:529-37.
10. Smallwood L, Allcock R, van Bockxmeer F, et al. Polymorphisms of the matrix metalloproteinase 9 gene and abdominal aortic aneurysm. Br J Surg 2008;95:1239-44.
11. Smallwood L, Warrington N, Allcock R, et al. Matrix metalloproteinase-2 gene variants and abdominal aortic aneurysm. Eur J Vasc Endovasc Surg 2009;38:169-71.
12. Hinterseher I, Bergert H, Kuhlisch E, et al. Matrix metalloproteinase 2 polymorphisms in a caucasian population with abdominal aortic aneurysm. J Surg Res 2006;133:121-8. (Pubitemid 43765757)
13. Hinterseher I, Krex D, Kuhlisch E, et al. Tissue inhibitor of metalloproteinase-1 (TIMP-1) polymorphisms in a caucasian population with abdominal aortic aneurysm. World J Surg 2007;31:2248-54. (Pubitemid 47620225)
14. Hinterseher I, Krex D, Kuhlisch E, et al. Analysis of tissue inhibitor of metalloproteinase-2 gene polymorphisms in a caucasian population with abdominal aortic aneurysms. Zentralbl Chir 2008;133:332-7.
15. Armani C, Curcio M, Barsotti MC, et al. Polymorphic analysis of the matrix metalloproteinase-9 gene and susceptibility to sporadic abdominal aortic aneurysm. Biomed Pharmacother 2007;61:268-71. (Pubitemid 46891720)
16. Deguara J, Burnand KG, Berg J, et al. An increased frequency of the 5A allele in the promoter region of the MMP3 gene is associated with abdominal aortic aneurysms. Hum Mol Genet 2007;16:3002-7. (Pubitemid 350131318)
17. Ogata T, Shibamura H, Tromp G, et al. Genetic analysis of polymorphisms in biologically relevant candidate genes in patients with abdominal aortic aneurysms. J Vasc Surg 2005;41:1036-42. (Pubitemid 40813036)
18. Jones GT, Phillips VL, Harris EL, et al. Functional matrix metalloproteinase-9 polymorphism (C-1562T) associated with abdominal aortic aneurysm. J Vasc Surg 2003;38:1363-7. (Pubitemid 37517670)
19. Wang X, Tromp G, Cole CW, et al. Analysis of coding sequences for tissue inhibitor of metalloproteinases 1 (TIMP1) and 2 (TIMP2) in patients with aneurysms. Matrix Biol 1999;18:121-4. (Pubitemid 29229696)
20. Yoon S, Tromp G, Vongpunsawad S, et al. Genetic analysis of MMP3, MMP9, and PAI-1 in finnish patients with abdominal aortic or intracranial aneurysms. Biochem Biophys Res Commun 1999;265:563-8.
21. Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and meta-analyses: the prisma statement. Ann Intern Med 2009;151:264-9.
22. Little J, Higgins JP, Ioannidis JP, et al. Strengthening the reporting of genetic association studies (STREGA): an extension of the strobe statement. Ann Intern Med 2009;150:206-15.
23. Dupont WD, Plummer WD Jr. Power and sample size calculations for studies involving linear regression. Control Clin Trials 1998;19:589-601. (Pubitemid 29057724)
24. Tilson MD 3rd, Ro CY. The candidate gene approach to susceptibility for abdominal aortic aneurysm: Timp1, HLA-DR-15, ferritin light chain, and collagen XI-alpha-1. Ann NY Acad Sci 2006;1085:282-90. (Pubitemid 47091988)
25. Eriksson P, Jormsjo-Pettersson S, Brady AR, et al. Genotype-phenotype relationships in an investigation of the role of proteases in abdominal aortic aneurysm expansion. Br J Surg 2005;92:1372-6. (Pubitemid 41546634)
26. Krishna SM, Dear AE, Norman PE, et al. Genetic and epigenetic mechanisms and their possible role in abdominal aortic aneurysm. Atherosclerosis 2010; 212:16-29.
27. Carrell TW, Burnand KG, Wells GM, et al. Stromelysin-1 (matrix metalloproteinase-3) and tissue inhibitor of metalloproteinase-3 are overexpressed in the wall of abdominal aortic aneurysms. Circulation 2002;105:477-82. (Pubitemid 34141705)
28. Newman KM, Ogata Y, Malon AM, et al. Identification of matrix metalloproteinases 3 (stromelysin-1) and 9 (gelatinase b) in abdominal aortic aneurysm. Arterioscler Thromb 1994;14:1315-20.
29. Silence J, Lupu F, Collen D, et al. Persistence of atherosclerotic plaque but reduced aneurysm formation in mice with stromelysin-1 (MMP-3) gene inactivation. Arterioscler Thromb Vasc Biol 2001;21:1440-5. (Pubitemid 34219805)
30. Thompson AR, Drenos F, Hafez H, et al. Candidate gene association studies in abdominal aortic aneurysm disease: a review and meta-analysis. Eur J Vasc Endovasc Surg 2008;35:19-30. (Pubitemid 350235228)